# DoD Breast Cancer, Clinical Research Extension Award

Source: https://welltoldgrants.com/grants/ht9425-23-bcrp-crea2-2-dod-breast-cancer-clinical-research-extension-award/  
Official notice: https://www.grants.gov/search-results-detail/348951

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make one award worth $9.3 million in total. Applications closed on September 26, 2023.

| Field | Value |
|---|---|
| Opportunity number | HT9425-23-BCRP-CREA2-2 |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | September 26, 2023 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 1 |
| Total funding | $9.3 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The FY23 BCRP Clinical Research Extension Award aims to extend or expand the data collection, follow-up, and analysis of breast cancer clinical studies. The intent of this mechanism is to increase the clinically relevant impact of breast cancer patient participation in clinical research by addressing the knowledge lost due to early trial termination, limited patient follow-up, or suboptimal sample and/or data collection and analysis. Patients’ contributions of tissue, serum, and other biologic specimens and their data are invaluable to saving lives. The BCRP has created this mechanism to help ensure that science values those contributions with research that maximizes their impact. The critical components of this award mechanism are: Impact: Research supported by the FY23 BCRP Clinical Research Extension Award will have the potential to extend or affect the impact of the previously funded clinical trial or study or will result in new impact and accelerate progress toward ending breast cancer. Research Scope: Although not all-inclusive, research proposed under the FY23 BCRP Clinical Research Extension Award may entail a deeper molecular analysis of clinical samples, initiation of new correlative studies, biomarker validation, or continuing clinical follow-up of patients enrolled in an open/ongoing or completed clinical trial. The proposed research may be hypothesis-testing or -generating or may be designed to generate clinically annotated and molecularly characterized experimental platforms, including patient-derived models or tissue arrays. Innovation is not a criterion for this award mechanism. Projects proposing to conduct clinical trials will not be supported. Feasibility: Preliminary data to support the scientific rationale and feasibility of the research approaches are required. The applicant must demonstrate availability of, and accessibility to, the necessary resources or populations to accomplish the proposed research. Data Evaluation and Sharing: Proposed research should be based on a study sample size that will ensure that the results support valid conclusions or will generate a meaningful hypothesis. It is the applicant’s responsibility to provide sufficient evidence that the sample size is appropriate to meet the study's objectives and outline the statistical methods and considerations they will employ in their data analysis.

## Questions people ask

### Is HT9425-23-BCRP-CREA2-2 still open?

No. It closed on September 26, 2023. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DoD Breast Cancer, Clinical Research Extension Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DoD Breast Cancer, Clinical Research Extension Award?

Closed September 26, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $9.3 million in total for one award.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.